HIV Testing

Test Phase Entered To Identify Survivors in HIV Population

Published in AIDS Weekly, June 24th, 1996

Hemagen Diagnostics, Inc., Waltham, Massachusetts, and Sheffield Medical Technologies reported they have entered the third and final development phase of a test to detect HIV positive individuals who are not likely to develop AIDS.

The test is based on a discovery by Dr. Jean-Claude Chermann, a French virologist who was one of the co-discoverers of HIV. Dr. Ricardo de Oliveira, Hemagen, said the test - known as an immunoassay - has been scheduled to undergo extensive clinical trials at centers of AIDS research in Marseille, France, and Sao Paulo, Brazil. The assay detects an antibody which Chermann has reported appears in virtually all of the 5 to 10 percent of HIV...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1996-06-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry